Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor {kappa}B-induced inflammation

Conclusions
The NF-B signaling pathway is activated and partly responsible for inflammation in polycystic kidney tissues. Targeting inflammation through resveratrol could be a new strategy for PKD treatment in the future.

Source: Nephrology Dialysis Transplantation - November 1, 2016 Category: Urology & Nephrology Authors: Wu, M., Gu, J., Mei, S., Xu, D., Jing, Y., Yao, Q., Chen, M., Yang, M., Chen, S., Yang, B., Qi, N., Hu, H., Wüthrich, R. P., Mei, C. Tags: BASIC SCIENCE Source Type: research